Search News
| 4.05 Delayed Data As of 3:59pm ET |  -0.20 / -4.71%Today’s Change | 3.20 Today|||52-Week Range 9.41 | -41.30% Year-to-Date |
| Previous close | 4.25 |
| Today’s open | 4.35 |
| Day’s range | 4.00 - 4.35 |
| Volume | 9,852 |
| Average volume (3 months) | 10,483 |
| Market cap | $38.4M |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +35.31% |
| Earnings growth (next 5 years) | +40.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 62.20 |
| Price/Book | 8.31 |
| Today’s change | Today’s % change | |
|---|---|---|
| CASICASI Pharmaceuticals... | -0.13 | -2.23% |
| APDNApplied DNA Sciences... | +0.01 | +1.17% |
| OPNTOpiant Pharmaceutica... | +0.08 | +0.52% |
| XENEXenon Pharmaceutical... | +0.60 | +7.59% |
| Next reporting date | August 10, 2018 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $778.7K |
| Annual profit (last year) | -$15.3M |
| Net profit margin | -1,970.92% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Natasha Giordano |
Chief Financial Officer Rita M. O'Connor |
Corporate headquarters Houston, Texas |
